Gene editing, a technology that enables scientists to change an organism's DNA, holds promise for the prevention and cure of such complex human diseases as cancer, heart disease, and sickle cell anemia.
The techniques used, including CRISPR, have generated a great deal of excitement for their efficiency and potential impact on human health, but they have also raised legal and ethical issues regarding germline and embryo manipulation, and many countries have banned such techniques due to these concerns.
The 2019 Radcliffe Institute science symposium will bring together leading international scientists, clinicians, and ethicists to explore case studies of particular gene therapies as well as the legal and bioethical implications of this research.
Free and open to the public. Registration is required.
We welcome and encourage students (of all levels and institutions) to attend our events. If you are a student, click here to register.
All other attendees, click here to register.
Welcome: Tomiko Brown-Nagin, dean, Radcliffe Institute for Advanced Study; Daniel P.S. Paul Professor of Constitutional Law, Harvard Law School; and professor of history, Faculty of Arts and Sciences, Harvard University
Framing Remarks: Immaculata De Vivo, life sciences advisor, Radcliffe Institute for Advanced Study; professor of medicine, Harvard Medical School; and professor of epidemiology, Harvard T.H. Chan School of Public Health
Session 1: Science and Society
Introduction by moderator: Charmaine Royal, associate professor of African and African American studies, biology, and community and family medicine, Duke University
Science keynote: Sylvain Moineau, Canada Research Chair in Bacteriophages, Department of Biochemistry, Microbiology, and Bio-informatics, Faculty of Science and Engineering, Université Laval (Quebec, Canada)
Jonathan Kimmelman, James McGill Professor and director of the Biomedical Ethics Unit, Department of Social Studies of Medicine, McGill University
Session 2: Case Studies: Heart Disease; Sickle Cell Anemia
Introduction by moderator Omar Abudayyeh, fellow, McGovern Institute for Brain Research, MIT
Vence Bonham, senior advisor to the director on genomics and health disparities, National Human Genome Research Institute
Kiran Musunuru, Associate Professor of Medicine, Perelman School of Medicine, University of Pennsylvania
Lunch break and student poster session (boxed lunches provided for all attendees)
Session 3: Case Studies: Genetic Engineering; Disability Rights
Introduction by moderator Pilar Ossorio, professor of law and bioethics, University of Wisconsin Law School; inaugural bioethics scholar in residence, Morgridge Institute for Research
Matthew Porteus, professor of pediatrics (stem cell transplantation), Stanford University School of Medicine
Rosemarie Garland-Thomson RI ’12, professor of English and bioethics in the Department of English and codirector of the Emory Disability Studies Initiative, Emory University
Session 4: Concluding Discussion
Concluding discussion with session moderators (Royal, Abudayyeh, Ossorio), moderated by Sharon Begley, senior writer, science and discovery, STAT
Closing Remarks: Immaculata De Vivo
Public reception and student poster session